Cargando…
The impact of a best practice advisory on inpatient prescribing of piperacillin-tazobactam
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614824/ https://www.ncbi.nlm.nih.gov/pubmed/36310781 http://dx.doi.org/10.1017/ash.2022.12 |
_version_ | 1784820278407200768 |
---|---|
author | Peterson, Katherine L. Tompkins, Bradley J. Ahern, John W. Smith, Lindsay M. |
author_facet | Peterson, Katherine L. Tompkins, Bradley J. Ahern, John W. Smith, Lindsay M. |
author_sort | Peterson, Katherine L. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9614824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96148242022-10-29 The impact of a best practice advisory on inpatient prescribing of piperacillin-tazobactam Peterson, Katherine L. Tompkins, Bradley J. Ahern, John W. Smith, Lindsay M. Antimicrob Steward Healthc Epidemiol Research Brief Cambridge University Press 2022-03-07 /pmc/articles/PMC9614824/ /pubmed/36310781 http://dx.doi.org/10.1017/ash.2022.12 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction in any medium, provided the original article is properly cited. |
spellingShingle | Research Brief Peterson, Katherine L. Tompkins, Bradley J. Ahern, John W. Smith, Lindsay M. The impact of a best practice advisory on inpatient prescribing of piperacillin-tazobactam |
title | The impact of a best practice advisory on inpatient prescribing of piperacillin-tazobactam |
title_full | The impact of a best practice advisory on inpatient prescribing of piperacillin-tazobactam |
title_fullStr | The impact of a best practice advisory on inpatient prescribing of piperacillin-tazobactam |
title_full_unstemmed | The impact of a best practice advisory on inpatient prescribing of piperacillin-tazobactam |
title_short | The impact of a best practice advisory on inpatient prescribing of piperacillin-tazobactam |
title_sort | impact of a best practice advisory on inpatient prescribing of piperacillin-tazobactam |
topic | Research Brief |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614824/ https://www.ncbi.nlm.nih.gov/pubmed/36310781 http://dx.doi.org/10.1017/ash.2022.12 |
work_keys_str_mv | AT petersonkatherinel theimpactofabestpracticeadvisoryoninpatientprescribingofpiperacillintazobactam AT tompkinsbradleyj theimpactofabestpracticeadvisoryoninpatientprescribingofpiperacillintazobactam AT ahernjohnw theimpactofabestpracticeadvisoryoninpatientprescribingofpiperacillintazobactam AT smithlindsaym theimpactofabestpracticeadvisoryoninpatientprescribingofpiperacillintazobactam AT petersonkatherinel impactofabestpracticeadvisoryoninpatientprescribingofpiperacillintazobactam AT tompkinsbradleyj impactofabestpracticeadvisoryoninpatientprescribingofpiperacillintazobactam AT ahernjohnw impactofabestpracticeadvisoryoninpatientprescribingofpiperacillintazobactam AT smithlindsaym impactofabestpracticeadvisoryoninpatientprescribingofpiperacillintazobactam |